← back to search

Qi Lv

Chinese Academy of Medical Sciences & Peking Union Medical College · CN
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Influenza Virus Research Studies, COVID-19 Clinical Research Studies, and Respiratory viral infections research.
h-index
29
citations
7,417
works
79
NIH funding
primary concept
Biology
email

Recent publications

Emergence of an ancient and pathogenic mammarenavirus
Emerging Microbes & Infections 2023cited by 19position: middledoi
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants
Virology Journal 2022cited by 14position: middledoi
SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration
Signal Transduction and Targeted Therapy 2021cited by 305position: middledoi
Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza
Signal Transduction and Targeted Therapy 2021cited by 75position: middledoi
Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its Variants
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
Cell 2020cited by 1,390position: middledoi
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Nature 2020cited by 1,230position: middledoi
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Nature 2020cited by 845position: middledoi
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Science 2020cited by 484position: middledoi
Age‐related rhesus macaque models of COVID‐19
Animal Models and Experimental Medicine 2020cited by 292position: middledoi
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Cell 2020cited by 288position: middledoi
Diverse biological characteristics and varied virulence of H7N9 from Wave 5
Emerging Microbes & Infections 2019cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Linlin Bao · National Clinical Research Center for Digestive Diseases3 papers (2019–2021)Chuan Qin · Rutgers, The State University of New Jersey3 papers (2019–2021)Wei Deng · Wuhan Institute of Virology2 papers (2021–2021)Qiang Wei · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2021–2021)Pin Yü · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2021–2021)Hong Gao · China-Japan Friendship Hospital2 papers (2021–2021)Yanfeng Xu · Qingdao University2 papers (2021–2021)Zhiqi Song · Zhongyuan University of Technology2 papers (2021–2021)Fengdi Li · CY Cergy Paris Université2 papers (2019–2021)Jiangning Liu · Academy of Medical Sciences2 papers (2021–2021)Jing Xue · University of Science and Technology of China2 papers (2021–2021)Yingxia Liu · Shenzhen Pingle Orthopedic Hospital1 papers (2019–2019)Xuan Yu · Changchun University of Science and Technology1 papers (2021–2021)Ming Liao · South China Agricultural University1 papers (2019–2019)Binbin Zhao · Shanghai University1 papers (2021–2021)Chuansong Quan · Fudan University1 papers (2019–2019)Guanpeng Wang · City Of Hope National Medical Center1 papers (2021–2021)Xiuping Sun · Nanyang Technological University1 papers (2021–2021)Shuran Gong · Affiliated Eye Hospital of Wenzhou Medical College1 papers (2021–2021)Li Zhou · Ministry of Ecology and Environment1 papers (2021–2021)